AcrySof^® IQ Toric

The latest in a long line of IOL innovations from Alcon, the new AcrySof^® IQ Toric lens takes the most trusted platform for precise astigmatism correction and adds the enhanced image quality of an aspheric lens, taking the toric IOL to a whole new level.

RESOURCES

	AcrySof^® IQ Toric Brochure Get the facts on AcrySof^® IQ Toric, including specs and studies.
	AcrySof^® IQ Toric Quick Guide Get up to speed on AcrySof^® IQ Toric with brief info, surgical considerations, and more.
	AcrySof^® IQ Toric Directions for Use Download the full technical specifications of the AcrySof^® IQ Toric IOL.
	AcrySof^® IQ Toric A-Constant FAQ Calculate a personalized A-Constant for AcrySof^® IQ Toric.
	AcrySof^® IQ Toric Patient Education Brochure Provide your patients with more information on cataract surgery and premium IOLs.
	AcrySof^® IQ Toric Calculator Makes precise surgical planning easy.

Where the Best Micro-Surgical Components Come Together as One

As part of the INTREPID^® Micro-Coaxial System, AcrySof^® IOLs offer advanced optics on a proven platform, to provide excellent ease of implantation and proven patient benefits.

New Technology Intraocular Lens (NTIOL) is a status given to lenses that provide patients with improved technology and new clinical benefits. As a member of the “Reduced Spherical Aberration” category established by CMS on February 27, 2006, Alcon’s AcrySof^® IQ Toric IOL recently received NTIOL status.

Ambulatory Surgery Centers are eligible to receive a payment adjustment of an additional $50 when AcrySof^® IQ Toric is used in cataract surgery on a Medicare beneficiary. This additional payment is effective through February 27, 2011.

Alcon is proud to develop the innovations that help shape the future of cataract surgery.

For more information on CMS and NTIOL, visit the CMS NTIOL Payment Page.

NTIOL Reimbursement Info

As of July 31, 2009, AcrySof® IQ Toric is a member of the “Reduced Spherical Aberration” category established by CMS on February 27, 2006.

$50 payment adjustment effective through February 27, 2011.

HCPCS Code for AcrySof® IQ Toric IOL:

Q1003 – New technology, intraocular lens, category 3

Please list as a separate line item on the claim form.

For more information, contact Alcon Reimbursement Services.

Couldn’t attend ASCRS 2009?

Catch up with video from the Live Surgery Symposium!

Robert Cionni, MD

They Eye Institute of Utah

Cataract Innovations and Refractive Pearls

$Cataract Innovations and Refractive Pearls$

WATCH NOW

Live Surgery at ASCRS: Cataract Innovations and Refractive Pearls
Cataract Surgical Case: AcrySof^® IQ Toric IOL

Are you a patient considering cataract surgery?

For more information about cataract surgery and premium intraocular lenses (IOLs), download the AcrySof^® IQ Toric Patient Education Brochure, or visit AllAboutVision.com.

Home About Conversation Invite a Colleague About Alcon Terms and Conditions Privacy Policy Other Alcon Products

Copyright © 2009 Alcon, Inc., a global company based in Hünenberg, Switzerland. Information contained here pertains to Alcon’s global operations and Alcon’s global product line. Not all products are approved in every market and approved labeling and instructions may vary by local country.

Currently AcrySof^® IQ Toric IOL is only available in the United States.

CAUTION: Federal law restricts this device to sale by or on the order of a physician. INDICATIONS: AcrySof^® IQ Toric IOL Models SN6AT3, SN6AT4, and SN6AT5 Posterior Chamber Intraocular lenses are intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia and pre-existing corneal astigmatism secondary to the removal of a cataractous lens in adult patients with or without presbyopia, who desire improved uncorrected distance vision, reduction of residual refractive cylinder and increased spectacle independence for distance vision. WARNINGS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Toric IOLs should not be implanted if the posterior capsule is ruptured, if the zonules are damaged, or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction; if necessary lens repositioning should occur as early as possible prior to lens encapsulation. All viscoelastics should be removed from both the anterior and posterior sides of the lens; residual viscoelastics may allow the lens to rotate. PRECAUTIONS: Studies have shown that color vision discrimination is not adversely affected in individuals with the AcrySof^® Natural IOL and normal color vision. The effect on vision of the AcrySof^® Natural IOL in subjects with hereditary color vision defects and acquired color vision defects secondary to ocular disease (e.g., glaucoma, diabetic retinopathy, chronic uveitis, and other retinal or optic nerve diseases) has not been studied. Do not resterilize; do not store over 45° C; use only sterile irrigating solutions such as BSS^® or BSS PLUS^® Sterile Intraocular Irrigating Solutions. ATTENTION: Reference the Directions for Use labeling for a complete listing of indications, warnings and precautions.